Literature DB >> 11095805

Methicillin-Resistant Staphylococcus aureus Infections.

.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) has continued to spread and cause serious nosocomial infections. Failure to control MRSA may result in higher rates of use of glycopeptides, which may, in turn, lead to higher rates of glycopeptide resistance. Resistance to glycopeptides has recently begun to appear in S. aureus. Transfer of glycopeptide-resistance genes from enterococci to S. aureus has been documented in laboratory experiments but has not yet been found in clinical isolates. Over time, MRSA is becoming more common in various subsets of the general population. Some studies claim that many MRSA-colonized outpatients and their close contacts have had no health care contacts, but these studies have usually not considered contacts in outpatient clinics. Several other recent studies have found that all or a vast majority of patients with MRSA have had frequent contact with health care providers. Failure to wash hands and disinfect equipment between patients, which has been commonly seen in studies of health care worker compliance with infection control measures, may explain much of the continuing spread. The source of spread of antibiotic-resistant microbes can be likened to an iceberg, with clinically obvious infections representing the tip of the iceberg and most of the spread coming from clinically inapparent colonized patients who represent most of the reservoir for transmission. Surveillance cultures to identify this reservoir are important to the control of spread with effective barrier precautions. Such precautions have been shown to reduce the spread of MRSA 15.6-fold compared with standard precautions.

Entities:  

Year:  1999        PMID: 11095805     DOI: 10.1007/s11908-999-0038-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  62 in total

1.  Epidural metastatic abscess: a rare complication of an infected osteosynthesis in a distal lower leg fracture.

Authors:  T Weber; T Fritz; S Kunze; V Ewerbeck; P J Meeder
Journal:  J Trauma       Date:  1999-02

2.  Staphylococcus aureus infections.

Authors:  S Blot; K Vandewoude; F Colardyn
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

3.  Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee.

Authors:  J S Garner
Journal:  Infect Control Hosp Epidemiol       Date:  1996-01       Impact factor: 3.254

4.  An epidural abscess due to resistant Staphylococcus aureus following epidural catheterisation.

Authors:  M Yuste; J Canet; M Garcia; M A Gil; F Vidal
Journal:  Anaesthesia       Date:  1997-02       Impact factor: 6.955

5.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

6.  Four cases of aggressive MRSA wound infection following head and neck surgery.

Authors:  M Parton; N J Beasley; G Harvey; D Houghton; A S Jones
Journal:  J Laryngol Otol       Date:  1997-09       Impact factor: 1.469

7.  Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain.

Authors:  J E Peacock; D R Moorman; R P Wenzel; G L Mandell
Journal:  J Infect Dis       Date:  1981-12       Impact factor: 5.226

8.  Methicillin-resistant Staphylococcus aureus in Europe.

Authors:  A Voss; D Milatovic; C Wallrauch-Schwarz; V T Rosdahl; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

9.  Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.

Authors:  H F Chambers; R T Miller; M D Newman
Journal:  Ann Intern Med       Date:  1988-10-15       Impact factor: 25.391

10.  Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection.

Authors:  N Markowitz; E L Quinn; L D Saravolatz
Journal:  Ann Intern Med       Date:  1992-09-01       Impact factor: 25.391

View more
  2 in total

1.  [Multiresistant pathogens in surgery].

Authors:  I F Chaberny; E Ott
Journal:  Unfallchirurg       Date:  2011-03       Impact factor: 1.000

2.  Antibiotics: MRSA prevention measures in German hospitals: results of a survey among hospitals, performed as part of the MRSA-KISS module.

Authors:  Iris F Chaberny; Anne Wriggers; Michael Behnke; Petra Gastmeier
Journal:  Dtsch Arztebl Int       Date:  2010-09-17       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.